<?xml version='1.0' encoding='utf-8'?>
<document id="20551241"><sentence text="Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes." /><sentence text="Human hepatocytes in primary culture are a very useful model to directly assess induction of gene expression by xenobiotics" /><sentence text=" We developed a cytochrome P450 (P450) activity cocktail assay using model substrates for the seven important P450s 1A2 (phenacetin), 2B6 (bupropion), 2C8 (amodiaquine), 2C9 (tolbutamide), 2C19 (S-mephenytoin), 2D6 (propafenone), and 3A4 (atorvastatin)"><entity charOffset="121-131" id="DDI-PubMed.20551241.s3.e0" text="phenacetin" /><entity charOffset="139-148" id="DDI-PubMed.20551241.s3.e1" text="bupropion" /><entity charOffset="156-167" id="DDI-PubMed.20551241.s3.e2" text="amodiaquine" /><entity charOffset="170-173" id="DDI-PubMed.20551241.s3.e3" text="2C9" /><entity charOffset="175-186" id="DDI-PubMed.20551241.s3.e4" text="tolbutamide" /><entity charOffset="216-227" id="DDI-PubMed.20551241.s3.e5" text="propafenone" /><entity charOffset="239-251" id="DDI-PubMed.20551241.s3.e6" text="atorvastatin" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e0" e2="DDI-PubMed.20551241.s3.e0" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e0" e2="DDI-PubMed.20551241.s3.e1" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e0" e2="DDI-PubMed.20551241.s3.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e0" e2="DDI-PubMed.20551241.s3.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e0" e2="DDI-PubMed.20551241.s3.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e0" e2="DDI-PubMed.20551241.s3.e5" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e0" e2="DDI-PubMed.20551241.s3.e6" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e1" e2="DDI-PubMed.20551241.s3.e1" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e1" e2="DDI-PubMed.20551241.s3.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e1" e2="DDI-PubMed.20551241.s3.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e1" e2="DDI-PubMed.20551241.s3.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e1" e2="DDI-PubMed.20551241.s3.e5" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e1" e2="DDI-PubMed.20551241.s3.e6" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e2" e2="DDI-PubMed.20551241.s3.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e2" e2="DDI-PubMed.20551241.s3.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e2" e2="DDI-PubMed.20551241.s3.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e2" e2="DDI-PubMed.20551241.s3.e5" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e2" e2="DDI-PubMed.20551241.s3.e6" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e3" e2="DDI-PubMed.20551241.s3.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e3" e2="DDI-PubMed.20551241.s3.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e3" e2="DDI-PubMed.20551241.s3.e5" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e3" e2="DDI-PubMed.20551241.s3.e6" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e4" e2="DDI-PubMed.20551241.s3.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e4" e2="DDI-PubMed.20551241.s3.e5" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e4" e2="DDI-PubMed.20551241.s3.e6" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e5" e2="DDI-PubMed.20551241.s3.e5" /><pair ddi="false" e1="DDI-PubMed.20551241.s3.e5" e2="DDI-PubMed.20551241.s3.e6" /></sentence><sentence text=" Metabolite formation was determined by liquid chromatography-tandem mass spectrometry in hepatocyte culture supernatants" /><sentence text=" Atorvastatin has not been previously assessed as a CYP3A probe drug"><entity charOffset="1-13" id="DDI-PubMed.20551241.s5.e0" text="Atorvastatin" /></sentence><sentence text=" We demonstrate highly selective atorvastatin ortho-hydroxylation by CYP3A4 by recombinant P450s" /><sentence text=" In human liver microsomes ortho-hydroxyatorvastatin formation was highly correlated with CYP3A4 protein content (r(s) = 0" /><sentence text="78, p &lt; 0" /><sentence text="0001, n = 150)" /><sentence text=" We profiled induction of these P450 activities in primary human hepatocytes after treatment with 30 microM atorvastatin, lovastatin, pravastatin, rosuvastatin, and simvastatin for 24 to 72 h"><entity charOffset="108-120" id="DDI-PubMed.20551241.s10.e0" text="atorvastatin" /><entity charOffset="122-132" id="DDI-PubMed.20551241.s10.e1" text="lovastatin" /><entity charOffset="134-145" id="DDI-PubMed.20551241.s10.e2" text="pravastatin" /><entity charOffset="147-159" id="DDI-PubMed.20551241.s10.e3" text="rosuvastatin" /><entity charOffset="165-176" id="DDI-PubMed.20551241.s10.e4" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e0" e2="DDI-PubMed.20551241.s10.e0" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e0" e2="DDI-PubMed.20551241.s10.e1" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e0" e2="DDI-PubMed.20551241.s10.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e0" e2="DDI-PubMed.20551241.s10.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e0" e2="DDI-PubMed.20551241.s10.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e1" e2="DDI-PubMed.20551241.s10.e1" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e1" e2="DDI-PubMed.20551241.s10.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e1" e2="DDI-PubMed.20551241.s10.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e1" e2="DDI-PubMed.20551241.s10.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e2" e2="DDI-PubMed.20551241.s10.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e2" e2="DDI-PubMed.20551241.s10.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e2" e2="DDI-PubMed.20551241.s10.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e3" e2="DDI-PubMed.20551241.s10.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s10.e3" e2="DDI-PubMed.20551241.s10.e4" /></sentence><sentence text=" Except for pravastatin, all statins induced P450 activities to various degrees, approximately in the order atorvastatin &gt; simvastatin &gt; lovastatin &gt; rosuvastatin"><entity charOffset="12-23" id="DDI-PubMed.20551241.s11.e0" text="pravastatin" /><entity charOffset="108-120" id="DDI-PubMed.20551241.s11.e1" text="atorvastatin" /><entity charOffset="123-134" id="DDI-PubMed.20551241.s11.e2" text="simvastatin" /><entity charOffset="137-147" id="DDI-PubMed.20551241.s11.e3" text="lovastatin" /><entity charOffset="150-162" id="DDI-PubMed.20551241.s11.e4" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e0" e2="DDI-PubMed.20551241.s11.e0" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e0" e2="DDI-PubMed.20551241.s11.e1" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e0" e2="DDI-PubMed.20551241.s11.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e0" e2="DDI-PubMed.20551241.s11.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e0" e2="DDI-PubMed.20551241.s11.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e1" e2="DDI-PubMed.20551241.s11.e1" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e1" e2="DDI-PubMed.20551241.s11.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e1" e2="DDI-PubMed.20551241.s11.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e1" e2="DDI-PubMed.20551241.s11.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e2" e2="DDI-PubMed.20551241.s11.e2" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e2" e2="DDI-PubMed.20551241.s11.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e2" e2="DDI-PubMed.20551241.s11.e4" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e3" e2="DDI-PubMed.20551241.s11.e3" /><pair ddi="false" e1="DDI-PubMed.20551241.s11.e3" e2="DDI-PubMed.20551241.s11.e4" /></sentence><sentence text=" Inducibility of P450s followed the order CYP2C8 &gt; CYP3A4 &gt; CYP2C9 &gt; CYP2B6 &gt; CYP2C19 approximately CYP2D6 &gt; CYP1A2"><entity charOffset="63-74" id="DDI-PubMed.20551241.s12.e0" text="2C9" /></sentence><sentence text=" The strongest induction was observed for amodiaquine N-desalkylation, which was induced approximately 20-fold" /><sentence text=" Quantitative reverse transcription-polymerase chain reaction confirmed corresponding changes on the mRNA level with even more dramatic induction up to almost 100-fold" /><sentence text=" These data suggest a broader inducing effect of statins on cytochrome P450s and possibly other absorption, distribution, metabolism, and excretion genes than previously known, thus further emphasizing their drug-drug interaction potential" /><sentence text=" Our cocktail assay should be helpful for economical use of human hepatocytes in the assessment of P450 induction by drugs and drug candidates" /><sentence text="" /></document>